Luis F Miranda1, Claudia O Rodrigues2, Shalini Ramachandran1, Eneida Torres1, Jian Huang1, Jammie Klim3, Dorothy Hehre1, Ian McNiece4, Joshua M Hare5, Cleide Y Suguihara1, Karen C Young6. 1. 1] Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida [2] Batchelor Children's Research Institute, University of Miami Miller School of Medicine, Miami, Florida. 2. 1] Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida [2] Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida. 3. Batchelor Children's Research Institute, University of Miami Miller School of Medicine, Miami, Florida. 4. Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida. 5. 1] Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida [2] Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida. 6. 1] Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida [2] Batchelor Children's Research Institute, University of Miami Miller School of Medicine, Miami, Florida [3] Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida.
Abstract
BACKGROUND: Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves recovery from neonatal HILI by improving angiogenesis. METHODS: Newborn rats assigned to normoxia (RA: 20.9% O2) or hyperoxia (90% O2) from postnatal day (P) 2 to 15, received daily injections of SCF 100 μg/kg or placebo (PL) from P15 to P21. Lung morphometry was performed at P28. Capillary tube formation in SCF-treated hyperoxia-exposed pulmonary microvascular endothelial cells (HPMECs) was determined by Matrigel assay. RESULTS: As compared with RA, hyperoxic-PL pups had decrease in alveolarization and in lung vascular density, and this was associated with increased right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and vascular remodeling. In contrast, SCF-treated hyperoxic pups had increased angiogenesis, improved alveolarization, and attenuation of pulmonary hypertension as evidenced by decreased RVSP, right ventricular hypertrophy, and vascular remodeling. Moreover, in an in vitro model, SCF increased capillary tube formation in hyperoxia-exposed HPMECs. CONCLUSION: Exogenous SCF restores alveolar and vascular structure in neonatal rats with HILI by promoting neoangiogenesis. These findings suggest a new strategy to treat lung diseases characterized by dysangiogenesis.
BACKGROUND:Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves recovery from neonatal HILI by improving angiogenesis. METHODS: Newborn rats assigned to normoxia (RA: 20.9% O2) or hyperoxia (90% O2) from postnatal day (P) 2 to 15, received daily injections of SCF 100 μg/kg or placebo (PL) from P15 to P21. Lung morphometry was performed at P28. Capillary tube formation in SCF-treated hyperoxia-exposed pulmonary microvascular endothelial cells (HPMECs) was determined by Matrigel assay. RESULTS: As compared with RA, hyperoxic-PL pups had decrease in alveolarization and in lung vascular density, and this was associated with increased right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and vascular remodeling. In contrast, SCF-treated hyperoxic pups had increased angiogenesis, improved alveolarization, and attenuation of pulmonary hypertension as evidenced by decreased RVSP, right ventricular hypertrophy, and vascular remodeling. Moreover, in an in vitro model, SCF increased capillary tube formation in hyperoxia-exposed HPMECs. CONCLUSION: Exogenous SCF restores alveolar and vascular structure in neonatal rats with HILI by promoting neoangiogenesis. These findings suggest a new strategy to treat lung diseases characterized by dysangiogenesis.
Authors: Lixin Sun; Ai-Min Hui; Qin Su; Alexander Vortmeyer; Yuri Kotliarov; Sandra Pastorino; Antonino Passaniti; Jayant Menon; Jennifer Walling; Rolando Bailey; Marc Rosenblum; Tom Mikkelsen; Howard A Fine Journal: Cancer Cell Date: 2006-04 Impact factor: 31.743
Authors: M C Heinrich; D C Dooley; A C Freed; L Band; M E Hoatlin; W W Keeble; S T Peters; K V Silvey; F S Ey; D Kabat Journal: Blood Date: 1993-08-01 Impact factor: 22.113
Authors: Karen C Young; Eneida Torres; Konstantinos E Hatzistergos; Dorothy Hehre; Cleide Suguihara; Joshua M Hare Journal: Circ Res Date: 2009-05-07 Impact factor: 17.367
Authors: Xiaomeng Ren; Vladimir Ustiyan; Minzhe Guo; Guolun Wang; Craig Bolte; Yufang Zhang; Yan Xu; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko Journal: Am J Respir Crit Care Med Date: 2019-11-01 Impact factor: 21.405
Authors: Karen C Young; Eneida Torres; Dorothy Hehre; Shu Wu; Cleide Suguihara; Joshua M Hare Journal: Pediatr Res Date: 2015-12-24 Impact factor: 3.756
Authors: Kasonya Guerra; Carleene Bryan; Frederick Dapaah-Siakwan; Ibrahim Sammour; Shelly Drummond; Ronald Zambrano; Pingping Chen; Jian Huang; Mayank Sharma; Sebastian Shrager; Merline Benny; Shu Wu; Karen C Young Journal: Respir Res Date: 2019-11-12